Access cutting-edge osteogenesis imperfecta treatment through this clinical trial at a research site in Wilmington. Study-provided care at no cost to qualified participants.
Quick Self-Assessment
See if you qualify for this Wilmington location
Preparing your pre-screening questions…
Access osteogenesis imperfecta specialists at no cost
This study follows strict safety protocols and ethical guidelines
All study-related osteogenesis imperfecta treatment provided free
Check if you qualify for this osteogenesis imperfecta clinical trial in Wilmington, DE
No-Cost Study Care
Local to Wilmington
Convenient for DE residents
Cutting-Edge Treatment
Access to innovative therapies
Expert Medical Care
Close monitoring by specialists
Possible Compensation*
For time and travel
*Compensation varies by study. Confirm details with coordinator.
Osteogenesis Imperfecta (OI) is a rare disorder of increased bone fragility characterized by fractures with minimal or absent trauma, dentinogenesis imperfecta (DI), and, in adult years, hearing loss. It is seen in both genders and all races. The clinical features of OI represent a continuum varying from perinatal lethality to individuals with severe skeletal deformities, mobility impairments, and very short stature to nearly asymptomatic individuals with a mild predisposition to fractures, normal stature, and normal lifespan. Fractures can occur in any bone, but are most common in the extremities. These disorders can be devastating and progressive and result in deformity, chronic pain, impaired function and loss of quality of life. The overall goal of this study is to answer specific question about the natural history of brittle bone diseases as defined by molecular etiology and to develop the foundation for prospective clinical studies.
Sponsor: Baylor College of Medicine
Yes, this clinical trial (NCT02432625) has an active research site in Wilmington, DE that is currently enrolling participants.
Clinical trials follow strict safety guidelines and ethical standards. This study has been reviewed and approved, and participants are closely monitored by medical professionals. You can withdraw at any time.
Many clinical trials offer compensation for your time and travel expenses. Specific compensation details will be discussed during the screening process. All study-related medical care is provided at no cost.
Absolutely. Participation is completely voluntary. You have the right to withdraw from the study at any time, for any reason, without penalty.
If you're searching for osteogenesis imperfecta treatment options in Wilmington, DE, this clinical trial (NCT02432625) may be an excellent opportunity. Clinical trials provide access to cutting-edge treatments that aren't yet available to the general public, often at no cost to participants.
Our Wilmington research site is actively enrolling participants for this clinical trial. You'll receive care from experienced osteogenesis imperfecta specialists who are at the forefront of medical research. All study-related care, including examinations, treatments, and monitoring, is provided at no cost to qualified participants.
Looking for more options? Browse all osteogenesis imperfecta clinical trials near you to find additional studies recruiting in your area.
See all pulmonary embolism clinical trials recruiting in Wilmington — not just this study.
Browse Pulmonary Embolism Trials in Wilmington →